Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Brain Res ; 1493: 13-8, 2013 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-23183040

RESUMO

It has been confirmed that gabapentin (GBP) induced a inhibition of the voltage-gated persistent sodium current in chronically compressed dorsal root ganglion (DRG) neurons. The persistent sodium current is found in excitable DRG neurons of painful diabetic neuropathy (PDN) rats where it is mediated by tetrodotoxin (TTX) sensitive sodium channels. Recently, many groups have used models of neurological disorder to explore the mechanism of GBP in neuropathic pain. There is no evidence, however, to explain the particular mechanism of GBP, including its analgesic actions in PDN rats. These issues were addressed in the present study. Using behavioral testing, we found that diabetes leads to mechanical allodynia and thermal hyperalgesia and these effects were reversed by a continuous GBP injection. To investigate the mechanism of GBP's reduction in neural excitability, we systematically analyzed the expression of Nav1.7 and p-ERK1/2 and tested the effect of GBP on these proteins. Diabetes significantly increased the excitability of DRG neurons and the expression of Nav1.7 and p-ERK1/2, and GBP significantly inhibited these changes. These results suggest that the inhibitory effect of GBP on the expression of Nav1.7 and p-ERK1/2 might be one of the analgesic mechanisms of action of GBP. This may partially explain the antinociceptive action of GBP in the PDN rats.


Assuntos
Aminas/farmacologia , Analgésicos/farmacologia , Ácidos Cicloexanocarboxílicos/farmacologia , Neuropatias Diabéticas/tratamento farmacológico , Hiperalgesia/tratamento farmacológico , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Canal de Sódio Disparado por Voltagem NAV1.7/metabolismo , Ácido gama-Aminobutírico/farmacologia , Animais , Modelos Animais de Doenças , Gabapentina , Gânglios Espinais/efeitos dos fármacos , Gânglios Espinais/metabolismo , Masculino , Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Proteína Quinase 3 Ativada por Mitógeno/metabolismo , Nociceptores/efeitos dos fármacos , Nociceptores/metabolismo , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...